Your browser doesn't support javascript.
loading
A Cost-effectiveness Analysis of Rabbit Antithymocyte Globulin Versus Antithymocyte Globulin-fresenius as Induction Therapy for Patients With Kidney Transplantation From Donation After Cardiac Death in China.
Xuan, Dennis; Chen, Guodong; Wang, Changxi; Yao, XingXing; Yin, Hongjun; Zhang, Lei; Xuan, Jianwei; Chen, Lizhong.
Afiliación
  • Xuan D; Department of Health Policy and Management, University of North Carolina Gillings School of Public Health; Chapel Hill, North Carolina.
  • Chen G; Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University; Guangzhou, China.
  • Wang C; Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University; Guangzhou, China.
  • Yao X; Sanofi S.A. China, Shanghai, China.
  • Yin H; Centennial Scientific Ltd., Shanghai, China.
  • Zhang L; Centennial Scientific Ltd., Shanghai, China.
  • Xuan J; Health Economic Research Institute, Sun Yat-sen University, Guangzhou, China.
  • Chen L; Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University; Guangzhou, China. Electronic address: clz1@medmail.com.cn.
Clin Ther ; 40(10): 1741-1751, 2018 10.
Article en En | MEDLINE | ID: mdl-30243768

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Inmunosupresores / Suero Antilinfocítico Tipo de estudio: Health_economic_evaluation / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: Clin Ther Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Inmunosupresores / Suero Antilinfocítico Tipo de estudio: Health_economic_evaluation / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: Clin Ther Año: 2018 Tipo del documento: Article